Recent evidence showed that a high level of AFP at baseline is also significantly associated with early tumor recurrence and poor prognosis of HCC in different clinical settings, such as after liver resection or liver transplantation [36,37]. The gene discussed is AFP; the disease is hepatocellular carcinoma.